News and Updates

Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020

Stage 2 of Health Cluster two-stage calls (2022) - Generalised feedback in view of preparing full proposal

Published on | 2 years ago

Programmes Health

In order to best ensure equal treatment, successful stage 1 applicants do not receive the evaluation summary reports (ESRs) for their proposals, but this generalised feedback with information and tips for preparing the full proposal.

HLTH-2022-STAYHLTH-01-two-stage 

Information & tips
Main suggestions to stage 2 applicants:

  • The proposal should address all the individual sub-criteria under in the appropriate section of the proposal. The methodology, inter-disciplinarily, current state of the art and – where relevant – use of AI should be clearly described.
  • Where relevant, aspects such as robustness of co-design, stigmatisation, pilot data and other feasibility data should be addressed in a satisfactory level of detail.
  • Overall impacts and how they can be reached should be clearly described.
  • Where relevant, prevention of obesity evidence, primary prevention and secondary prevention should be considered - actions for people who are at greater risk than the average of becoming obese or timely prevention or how to implement the existing evidence.
  • If the proposal contains clinical studies, please read carefully the definition and guidance on the template ‘Information on clinical studies' published on the call page in the Participant Portal (https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/information-on-clinical-studies_he_en.docx) and remember to upload the template filled in when submitting your proposal.
 
HORIZON-HLTH-2022-DISEASE-06-two-stage
 
Information & tips
Main suggestions to stage 2 applicants:
  • The proposal should address all the individual sub-criteria under in the appropriate section of the proposal. The methodology, current state of the art and – where relevant – use of AI should be clearly described.
  • Where relevant, preliminary data (even if unpublished) should be presented.
  • Where relevant, detailed information on epitopes should be given.
  • If the proposal contains clinical studies, please read carefully the definition and guidance on the template ‘Information on clinical studies' published on the call page in the Participant Portal (https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/information-on-clinical-studies_he_en.docx) and remember to upload the template filled in when submitting your proposal
 
HORIZON-HLTH-2022-TOOL-12-two-stage

Information & tips
Main suggestions to stage 2 applicants:

  • The proposal should address all the individual sub-criteria under in the appropriate section of the proposal. The methodology, current state of the art and – where relevant – use of AI should be clearly described.
  • The quality of data and standards should be emphasised.
  • If the proposal contains clinical studies, please read carefully the definition and guidance on the template ‘Information on clinical studies' published on the call page in the Participant Portal (https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/information-on-clinical-studies_he_en.docx) and remember to upload the template filled in when submitting your proposal.

 

In stage 2 off all above mentioned proposals, there will be a chance to address or clarify these issues. Please bear in mind that the  full proposal will now be evaluated more in-depth and possibly by a new group of outside experts.

Please make sure that the full proposal is consistent with your short outline proposal. It may not differ substantially. The project must remain the same.

Source: Funding and Tender Portal

myOVERVIEW
- sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1488 articles available search in articles 

Testimonial

image of SAPHIRe - Securing the Adoption of Personalised Medicin in Regions

SAPHIRe - Securing the Adoption of Personalised Medicin in Regions

The Department of Economy, Science and Innovation of the Flemish government coordinates the Horizon 2020 Coordination and Support Action SAPHIRe, which started on 1 December 2018. The aim of the project is to secure the adoption of personalised medicine in all European regions, including sparsely populated and remote regions and regions with different innovation capacities. 

The activities of SAPHIRe are complementary to the smart specialisation partnership on personalised medicine – S3P4PM, which is also coordinated by the Department of Economy, Science and Innovation.